Zacks
ARCT Stock Plunges 59% in Three Months: Here's What You Need to Know
➖
AI Sentiment
Neutral
4/10
- Home
- ARCT
as of 12-05-2025 3:46pm EST
$7.05
+$0.22
+3.22%
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Chart Type:
Time Range:
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 194.1M | IPO Year: | N/A |
| Target Price: | $38.67 | AVG Volume (30 days): | 943.4K |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.46 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.85 - $24.17 | Next Earning Date: | 11-10-2025 |
| Revenue: | $97,601,000 | Revenue Growth: | -39.15% |
| Revenue Growth (this year): | -39.24% | Revenue Growth (next year): | -9.38% |
AI-Powered ARCT Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 71.43%
71.43%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Arcturus Therapeutics Holdings Inc. News
ARCT Breaking Stock News: Dive into ARCT Ticker-Specific Updates for Smart Investing
Compare ARCT vs Leading Stocks
See how ARCT stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ARCT Arcturus Therapeutics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.